Amtech Esters IPO GMP Today, Price & Details
Amtech Esters IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Amtech Esters
Amtech Esters is venturing into the public market via the SME segment on the BSE, aiming to raise capital through an Initial Public Offering (IPO). The company operates within the chemical manufacturing sector, specifically focusing on the production of esters, which are crucial intermediates used in various industries. Its scale of operations, as indicated by its recent revenue figures, positions it as a small to medium-sized enterprise within this competitive landscape. The IPO presents an opportunity for investors to gain exposure to this niche segment of the chemical industry.
The company has demonstrated a positive financial trajectory, with reported revenue standing at ₹40.75 Cr and a Profit After Tax (PAT) of ₹4.22 Cr. This translates to an Earnings Per Share (EPS) of ₹4.78. The IPO structure is predominantly a fresh issue, with the company aiming to raise ₹17.88 Cr out of a total issue size of ₹18 Cr. This indicates that the majority of the funds will be infused directly into the company for its growth and operational expansion, rather than being an exit route for existing shareholders.
Amtech Esters aims to leverage the capital raised to bolster its manufacturing capabilities and expand its product portfolio. In a sector that often benefits from economies of scale and technological advancements, the company's strategic use of proceeds will be critical for enhancing its competitive positioning. The focus on fresh issuance suggests a growth-oriented strategy, where the infusion of funds is intended to drive future expansion and solidify its market presence. The IPO, managed by Credora Partners Pvt.Ltd., with Maashitla Securities Pvt.Ltd. as the registrar, marks a significant step in its journey.
Amtech Esters IPO — Investment Analysis
The Amtech Esters IPO is priced at a band of ₹71 to ₹75 per share, with a face value of ₹10. Considering the company's reported Earnings Per Share (EPS) of ₹4.78 for the period, this translates to a Price-to-Earnings (P/E) multiple of approximately 15.69x at the upper end of the price band. This valuation needs to be assessed against industry peers and the company's growth prospects. While a P/E of 15.69x isn't excessively high for a manufacturing entity, it's crucial to see if the company's future earnings can justify this valuation, especially within the SME segment where valuations can sometimes be more aggressive.
Financially, Amtech Esters has reported a revenue of ₹40.75 Cr and a PAT of ₹4.22 Cr. This indicates a PAT margin of roughly 10.35%. While specific details on EBITDA and return ratios like Return on Net Worth (RONW) and Return on Capital Employed (ROCE) are not provided in the data, a healthy PAT margin is a positive signal. However, a comprehensive understanding of its financial health would require a deeper dive into its balance sheet, cash flow statements, and historical performance trends to ascertain its true profitability and efficiency.
The company's growth outlook is intrinsically linked to the demand for its ester products and its ability to scale up operations effectively with the IPO proceeds. Key risks to consider include the inherent volatility of the chemical sector, potential raw material price fluctuations, and competition from larger players. Furthermore, as an SME IPO, there are generally higher risks associated with liquidity and transparency compared to mainboard listings. The fact that this is a pure fresh issue of ₹17.88 Cr out of a total ₹18 Cr issue size means the funds will directly go into the company, which is a positive for growth, but it also means there's no OFS component to gauge existing investor confidence.
Subscription levels for SME IPOs can often be a strong indicator of market sentiment. High subscription from Qualified Institutional Buyers (QIBs), High Net-worth Individuals (HNIs), and Retail Individual Investors (RIIs) typically suggests strong demand and can lead to a positive listing. Conversely, lukewarm subscription might signal caution. It's important for investors to monitor these subscription figures closely as they are released. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Amtech Esters IPO — Pros & Cons
Strengths
- The company has reported a healthy Profit After Tax (PAT) of ₹4.22 Cr on a revenue of ₹40.75 Cr, indicating a commendable PAT margin of approximately 10.35%. This suggests efficient operational management and pricing power within its niche.
- The IPO is predominantly a fresh issue, with ₹17.88 Cr being raised out of a total issue size of ₹18 Cr. This signifies that the funds will be directly injected into the company for growth initiatives, which is generally positive for long-term value creation.
- The company operates in the chemical manufacturing sector, specifically focusing on esters, which are essential in various downstream industries. This niche focus can provide a degree of stability and specialized demand for its products.
- The Earnings Per Share (EPS) of ₹4.78, coupled with a P/E ratio of approximately 15.69x at the upper band, suggests a valuation that, while not deeply discounted, may offer reasonable entry points if future growth materializes as expected.
- The IPO is listed on the BSE SME platform, which often provides an avenue for smaller, growth-oriented companies to access public capital markets and gain visibility.
Risks
- The provided financial data is limited, with no specific details on EBITDA, RONW, or ROCE, making a comprehensive assessment of the company's financial health and efficiency challenging. Investors need to rely on limited reported figures.
- As an SME IPO, Amtech Esters may face higher risks related to market liquidity and price volatility post-listing compared to mainboard-listed companies. This could impact the ease of trading shares for investors.
- The chemical sector can be susceptible to cyclical demand, raw material price fluctuations, and stringent environmental regulations, which could pose challenges to sustained profitability and growth.
- The P/E ratio of approximately 15.69x, while not exorbitant, needs to be justified by robust future earnings growth. Any slowdown in growth could lead to valuation concerns for investors.
- The company's scale of operations, based on its revenue of ₹40.75 Cr, is relatively small. This might limit its ability to compete effectively with larger, established players in the chemical industry.
Amtech Esters IPO Details
| Company Name | Amtech Esters |
|---|---|
| IPO Type | SME |
| Exchange | BSE |
| Price Band | ₹71 - ₹75 |
| Face Value | ₹10 per share |
| Lot Size | 1600 shares |
| Min Investment | ₹120,000 |
| Total Issue Size | ₹18.00 Cr |
|---|---|
| Fresh Issue | ₹17.88 Cr |
| Registrar | Maashitla Securities Pvt.Ltd. |
| Lead Manager | Credora Partners Pvt.Ltd. |
| IPO Status | Open |
Amtech Esters IPO Dates
Amtech Esters IPO GMP Today
The Grey Market Premium (GMP) for Amtech Esters IPO is ₹7, indicating an expected listing at ₹82 (+9.3% premium).
📈 Amtech Esters GMP Trend (Last 4 Days)
| Date | GMP (₹) | Est. Listing (₹) | Sauda Rate (₹) | Change |
|---|---|---|---|---|
| 09 Sep 2026 | +₹7 | ₹82 | - | - |
| 08 Sep 2026 | +₹5 | ₹80 | - | ▼ ₹-2 |
| 07 Sep 2026 | +₹5 | ₹80 | - | - |
| 05 Sep 2026 | +₹5 | ₹80 | - | - |
Amtech Esters IPO — Key Highlights
- Amtech Esters is looking to raise ₹18 Cr through its IPO on the BSE SME platform.
- The company has posted a revenue of ₹40.75 Cr and a PAT of ₹4.22 Cr.
- The IPO features a pure fresh issue of ₹17.88 Cr, indicating a focus on business expansion.
- The P/E ratio at the upper price band of ₹75 stands at approximately 15.69x.
- The lot size for the IPO is 1600 shares, with a price band of ₹71 - ₹75.
- Maashitla Securities Pvt.Ltd. is the registrar, and Credora Partners Pvt.Ltd. is the lead manager for this issue.
Amtech Esters Financial Performance
| Revenue | ₹40.75 Cr |
|---|---|
| PAT | ₹4.22 Cr |
| EPS | ₹4.78 |
Amtech Esters IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹4.78 |
|---|---|
| P/E Ratio | 15.69x |
| Debt/Equity | 0.000 |
Return Metrics
Amtech Esters IPO Reservation / Allocation
Amtech Esters IPO Lead Manager & Registrar
Book Running Lead Manager
Credora Partners Pvt.Ltd.
IPO Registrar
Maashitla Securities Pvt.Ltd.
Amtech Esters IPO — Frequently Asked Questions
What is Amtech Esters IPO GMP today?
As of today, the Grey Market Premium (GMP) for Amtech Esters IPO is ₹7 per share, indicating a potential listing premium of 9.3% above the issue price of ₹75.
What is the price band and lot size of Amtech Esters IPO?
Amtech Esters IPO has a price band of ₹71 to ₹75 per equity share with a face value of ₹10. The minimum lot size is 1600 shares, requiring a minimum investment of ₹120,000 at the upper band.
What are the important dates for Amtech Esters IPO?
Amtech Esters IPO opens for subscription on 09 Sep 2026 and closes on 11 Sep 2026. Allotment is expected on 15 Sep 2026. The shares are expected to list on BSE on 17 Sep 2026.
What is the investor category allocation in Amtech Esters IPO?
The shares are reserved as follows — Qualified Institutional Buyers (QIB): 0.00%, Non-Institutional Investors (NII/HNI): 0.00%, and Retail Individual Investors: 35.05%.
How can I apply for Amtech Esters IPO?
You can apply for Amtech Esters IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is Maashitla Securities Pvt.Ltd..
What is Amtech Esters IPO price band and lot size?
The Amtech Esters IPO is open with a price band set between ₹71 and ₹75 per share. Each lot comprises 1600 shares. This means the minimum investment required is ₹120,000 (1600 shares x ₹75).
The face value of each share is ₹10. This price band and lot size are crucial for investors looking to participate in the offering.
Is Amtech Esters IPO worth investing in?
Amtech Esters presents a mixed picture. On the positive side, it has demonstrated a healthy PAT margin of around 10.35% and is raising capital primarily through a fresh issue, indicating a focus on growth. The P/E of approximately 15.69x seems reasonable for a chemical manufacturer.
However, the limited financial data available, especially regarding return ratios, and the inherent risks associated with SME listings are key concerns. Investors should carefully weigh the potential for growth against these risks. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Amtech Esters IPO GMP today?
Grey Market Premium (GMP) for IPOs is an unofficial indicator of demand and potential listing gains. While specific GMP figures for Amtech Esters are not provided here, investors often track these trends. A positive GMP suggests strong investor interest and potential for listing above the issue price, possibly in the range of 10-20% or more.
However, it's crucial to remember that GMP is speculative and should not be the sole basis for investment decisions.
How to apply for Amtech Esters IPO?
You can apply for the Amtech Esters IPO through the ASBA (Application Supported by Blocked Amount) facility via your bank or through your stockbroker's trading platform. Retail investors can also apply using the UPI (Unified Payments Interface) mechanism. The registrar for the IPO is Maashitla Securities Pvt.Ltd.
Your funds will remain blocked in your bank account until the shares are allotted, after which they will be debited if successful, or unblocked if unsuccessful.